Literature DB >> 28157099

Sex Impact on Tau-Aggregation and Postsynaptic Protein Levels in the P301L Mouse Model of Tauopathy.

Lucia Buccarello1,2, Giuliano Grignaschi1, Anna Maria Castaldo1,3, Alessia Di Giancamillo2, Cinzia Domeneghini2, Roberto Cosimo Melcangi4, Tiziana Borsello1,4.   

Abstract

P301L transgenic (tg) mice well mimic features of human tauopathies and provide a good model for investigating the role of tau in neurodegenerative events. We here analyzed the possible interactions among phosphorylation of tau (p-tau), spine injury, neuronal death, and sex in the P301L mouse model of tauopathy. When compared to control mice (ctr), P301L transgenic mice (tg) presented a lower body weight, reduced survival rate, hyperphosphorylated tau, spine injury, and neuronal loss in both cerebral cortex and hippocampus at 15 months of age. Importantly, we found that pathological features were more pronounced in female than male tg mice. Recent reports underline that tau may be localized within both pre- and post-synaptic compartments, suggesting that it may possibly induce or contribute to synaptic dysfunction. Therefore, we focused our attention on tau localization at dendritic spines. We detected high levels of both tau and p-tau in dendritic spine of P301L transgenic mice. In addition, p-tau correlated with a significant reduction of post-synaptic markers, such as GluN2A, GluN2B, GluA1, GluA2, Drebrin, and PSD-95, in P301L mice. The p-tau levels are higher in female than in male mice, and the increased p-tau was consistent with a proportional decrease in the post-synaptic marker levels analyzed. The P301L-tg females showed a more severe synaptopathy compared to males. Future investigations on the postsynaptic role of p-tau will be necessary to understand its toxic effects and provide insights into new therapeutic targets for maintaining spine integrity, highlighting the importance of tau toxicity as well as the impact of sex on tau-pathology.

Entities:  

Keywords:  Hyperphosphorylated tau; post-synaptic markers; sex; synaptopathy; tauopathy

Mesh:

Substances:

Year:  2017        PMID: 28157099     DOI: 10.3233/JAD-161087

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  8 in total

1.  Increased tau phosphorylation follows impeded dopamine clearance in a P301L and novel P301L/COMT-deleted (DM) tau mouse model.

Authors:  Jeremy Koppel; Heidy Jimenez; Leslie Adrien; Eric H Chang; Anil K Malhotra; Peter Davies
Journal:  J Neurochem       Date:  2018-11-12       Impact factor: 5.372

2.  In Vitro and In Vivo Evaluation of GSK-3 Radioligands in Alzheimer's Disease: Preliminary Evidence of Sex Differences.

Authors:  Ashley C Knight; Cassis Varlow; Junchao Tong; Neil Vasdev
Journal:  ACS Pharmacol Transl Sci       Date:  2021-07-20

3.  Anesthesia promotes acute expression of genes related to Alzheimer's disease and latent tau aggregation in transgenic mouse models of tauopathy.

Authors:  John David Eun; Heidy Jimenez; Leslie Adrien; Adam Wolin; Philippe Marambaud; Peter Davies; Jeremy L Koppel
Journal:  Mol Med       Date:  2022-07-20       Impact factor: 6.376

Review 4.  Practical considerations for choosing a mouse model of Alzheimer's disease.

Authors:  Joanna L Jankowsky; Hui Zheng
Journal:  Mol Neurodegener       Date:  2017-12-22       Impact factor: 14.195

Review 5.  Sex Differences in Autophagy Contribute to Female Vulnerability in Alzheimer's Disease.

Authors:  Erin E Congdon
Journal:  Front Neurosci       Date:  2018-06-22       Impact factor: 4.677

Review 6.  Steroids and Alzheimer's Disease: Changes Associated with Pathology and Therapeutic Potential.

Authors:  Yvette Akwa
Journal:  Int J Mol Sci       Date:  2020-07-07       Impact factor: 5.923

Review 7.  Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical Research.

Authors:  Jessica L Dennison; Natalie R Ricciardi; Ines Lohse; Claude-Henry Volmar; Claes Wahlestedt
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

8.  The impact of pimavanserin on psychotic phenotypes and tau phosphorylation in the P301L/COMT- and rTg(P301L)4510 mouse models of Alzheimer's disease.

Authors:  Heidy Jimenez; Leslie Adrien; Adam Wolin; John Eun; Eric H Chang; Ethan S Burstein; Jesus Gomar; Peter Davies; Jeremy Koppel
Journal:  Alzheimers Dement (N Y)       Date:  2022-02-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.